Posted 23 January, 2024
Timber Pharmaceuticals, Inc. appointed new CEO
CEO Change detected for ticker OTC:TMBRQ in a 8-K filed on 23 January, 2024.
Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company's subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.
$1.72K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company's subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc. Also effective as of the closing of the Asset Sale, Alan Mendelsohn, Chief Medical Officer, no longer serves as Chief Medical Officer of the Company and any other positions with the Company's subsidiaries, as applicable and has been offered employment with LEO Spiny Merger Sub, Inc.
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.